Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies

NCT00438178

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +3 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

MD Anderson Cancer Center Houston, Texas, United States

Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

NCT00640796

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +19 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

NCT00810602

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Malignancies, +5 more
Locations: University of Michigan Cancer Center Ann Arbor, Michigan, United States

Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors

NCT01725555

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +4 more
Locations: KFUE Uppsala, Sweden

View Trial Details

Completed

Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias

NCT00920140

Conditions: Cancer, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Duarte, California, United States

GSK Investigational Site Los Angeles, California, United States

GSK Investigational Site San Francisco, California, United States

View all 28 locations

View Trial Details

Completed

Rituximab for Prevention of Chronic GVHD

NCT00379587

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +14 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Adult Double Cord Blood Transplant Study

NCT00514579

Conditions: Bone Marrow Diseases, Cord Blood Stem Cell Transplantation, Hematologic Diseases, +8 more
Locations: City of Hope Duarte, California, United States

University of California at Los Angeles Los Angeles, California, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States

View Trial Details

Completed

Cyclophosphamide, VELCADE, DOXIL, and Dexamethasone, (CVDD) in Newly Diagnosed Patients With Multiple Myeloma (MM)

NCT00750815

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

NCT00440765

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: 's-Hertogenbosch, Netherlands

Alkmaar, Netherlands

Amersfoort, Netherlands

Amstelveen, Netherlands

View all 44 locations

View Trial Details

Completed

A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation

NCT00894049

Conditions: Allogeneic Cell Transplantaion, Allograft, Hematologic Diseases, +6 more
Locations: CHU Bordeaux Pessac, France

CHU Clermont-Ferrand, France

CHU Lyon, France

Institut Paoli-Calmettes Marseille, France

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions